Cambridge Antibody Technology: Pioneers in Therapeutic Antibody Development

Foundation and Key Figures : Founded in 1989 by Sir Greg Winter, David Chiswell, and John McCafferty with contributions from the Medical Research Council.

Innovative Technology : Pioneered the use of Phage Display technology for antibody discovery and development.

First Blockbuster Drug : Created adalimumab (Humira), the first fully human antibody blockbuster drug.

Acquisition : Acquired by AstraZeneca in 2006 for £702 million and integrated with MedImmune in 2007.

Nobel Prize : Sir Greg Winter, one of the founders, shared the Nobel Prize for Chemistry in 2018 for his work on phage display of peptides and antibodies.

Other Significant Drugs : Also discovered belimumab (Benlysta), used for systemic lupus erythematosus.

Legacy : Known as a jewel in the British biotech industry, contributing significantly to therapeutic antibody development.